Summary
Double photon absorptiometry comparison was done of lumbar bone mineral content (BMC) values in 40 women with well-compensated non-insulin-dependent diabetes mellitus (type II) and on dietary and/or oral hypoglycemic treatment, and 35 age-matched non-diabetic women, to determine the presence and degree of osteoporosis in this type of diabetes by means of a highly precise and sensitive method. No difference between the two groups was noted as regards blood calcium, phosphorus, PTH and thyrocalcitonin, and urinary calcium and phosphorus. BMC, on the other hand, was significantly lower in the diabetics, both in L2,L3,L4 and in L4 alone. No significant difference could be discerned between patients on diet and those on drugs. It can thus be maintained that osteoporosis is a possible complication of type II diabetes and may appear even in the absence of its classical complications.
Similar content being viewed by others
References
Burkhardt R., Moser W., Bartl R., Mahl G.: Is diabetic osteoporosis due to microangiopathy? —Lanceti, 844, 1981.
Christiansen C., Christiansen M. S., McNair P., Nielsen B., Madsbad S.: Vitamin D metabolites in diabetic patients: decreased serum concentration of 24,25-dihydroxyvitamin D— Scand. J. clin. Lab. Invest.42, 487, 1982.
Dixit P. K., Ekstrom R. A.: Decreased breaking strength of diabetic rat bone and its improvement by insulin treatment—Calcif. Tiss. int.32, 195, 1980.
Frazer T. E., White N. H., Hough S., Santiago J. V., McGee B. R., Bryce G., Mallon J., Avioli L. V.: Alterations in circulating vitamin D metabolites in the young insulin-dependent diabetic—J. clin. Endocrinol.53, 1154, 1981.
Gertner J. M., Tamborlane W. V., Horst R. L., Sherwin R. S., Felig P., Genel M.: Mineral metabolism in diabetes mellitus: changes accompanying treatment with a portable subcutaneous insulin infusion system—J. clin. Endocrinol.50, 862, 1980.
Heath H. III,Lambert P. W., Service F. J., Arnaud S. B.: Calcium homeostasis in diabetes mellitus—J. clin. Endocrinol.49, 462, 1979.
Hough S., Russel J. E.: Calcium homeostasis in chronic streptozotocin-induced diabetes mellitus in the rat—Amer. J. Physiol.232, 451, 1982.
Hoskins B., Feibelman R. Y., Koury A. M., Taylor R.: Effectiveness of insulin therapy on altered calcium transport in diabetic rats—Diabetes28, 1088, 1979.
Hoskins B., Scott J. M.: Effects of insulin on urinary calcium excretion by diabetic rats in the absence of blood glucose control—Acta diabetol. lat.21, 263, 1984.
Isaia G. C., Gastaldi M., Guidetti D., Mussetta M., Salamano G., Giusti M.: Reproducibility of lumbar BMC valued with the technique of the double photonic ray—Miner. metabol. Res.5, 69, 1985.
Ishida H., Seino Y., Matsukura S., Ikeda M., Yawata M., Yamashita G., Ishizuka S., Imura H.: Diabetic osteopenia and circulating levels of vitamin D metabolites in type 2 (non-insulin-dependent) diabetes—Metabolism34, 797, 1985.
Ishida H., Seino Y., Tsuda K., Takemura J., Nishi S., Ishizuka S., Imura H.: Effects of streptozotocin-induced diabetes on circulating levels of vitamin D metabolites—Acta endocrinol. (Kbh.)104, 96, 1983.
Klonoff D.C., Karam J.H.: Diabetes mellitus and risk of skeletal fracture—New Engl. J. Med.304, 115, 1981.
Krolner B., Nielsen S. P.: Measurement of bone mineral content (BMC) of the lumbar spine. I. Theory and application of a new two-dimensional dual-photon attenuation method—Scand. J. clin. Lab. Invest.40, 653, 1980.
Levin M. E., Boisseau V. C., Avioli L. V.: Effects of diabetes mellitus on bone mass in juvenile and adult-onset diabetes—New Engl. J. Med.294, 241, 1976.
Levy J., Teitelbaum S. L., Gavin J. R. III,Fausto A., Kurose H., Avioli L. V.: Bone calcification and calcium homeostasis in rats with non-insulin-dependent diabetes induced by streptozocin —Diabetes34, 365, 1985.
Mazess R. B.: Diabetes mellitus and risk of skeletal fracture—New Engl. J. Med.304, 115, 1981.
McNair P., Madsbad S., Christiansen C. Christiansen M. S., Faber O. K., Binder C., Transbøl I.: Bone loss in diabetes: effects of metabolic state—Diabetologia17, 283, 1979.
McNair P., Madsbad S., Christiansen C., Faber O. K., Transbøl I., Binder C.: Osteopenia in insulin treated diabetes mellitus. Its relation to age at onset, sex and duration of disease —Diabetologia15, 87, 1978.
McNair P., Madsbad S., Christiansen M. S., Christiansen C., Faber O. K., Binder C., Transbøl I.: Bone mineral loss in insulin-treated diabetes mellitus: studies on pathogenesis— Acta endocrinol. (Kbh.)90, 463, 1979.
Menczel J., Makin M., Robin G., Jaye I., Naor E.: Prevalence of diabetes mellitus in Jerusalem: its association with presenile osteoporosis—Israel J. med. Sci.8, 918, 1972.
Nguyen N. U., Dumoulin G., Henriet M. T., Wolf J. P., Berthelay S.: Calcium phosphorus homeostasis during oral glucose load in man—Hormone metabol. Res.16, 264, 1984.
Raskin P., Pak C. Y. C.: The effect of chronic insulin therapy on phosphate metabolism in diabetes mellitus—Diabetologia21, 50, 1981.
Raskin P., Stevenson M. R. M., Barilla D. E., Pak C. Y. C.: The hypercalciuria of diabetes mellitus: its amelioration with insulin—Clin. endocrinol. (Oxf.)9, 329, 1978.
Rosenbloom A. L., Lezotte D. C., Weber T. F., Gudat J., Heller D. R., Weber M. L., Klein S., Kennedy B. B.: Diminution of bone mass in childhood diabetes—Diabetes26, 1052 1977.
Schneider L. E., Nowosielski L. M., Schedl H. P.: Insulin-treatment of diabetic rats: effects on duodenal calcium absorption—Endocrinology100, 67, 1977.
Schneider L. E., Omdahl J. L., Schedl H. P.: Effects of vitamin D and its metabolites on calcium transport in the diabetic rat—Endocrinology99, 793, 1976.
Schneider L. E., Schedl H. P., McCain T., Haussler M. R.: Experimental diabetes reduces circulating 1,25-dihydroxyvitamin D in the rat—Science196, 1452, 1977.
Shires R., Teitelbaum S. L., Bergfeld M. A., Fallon M. D., Slatopolsky E., Avioli L. V.: The effect of streptozotocin-induced chronic diabetes mellitus on bone and mineral homeostasis in the rat—J. Lab. clin. Med.97, 231, 1981.
Shore R. M., Chesney R. W., Mazess R. B., Rose P. G., Bargman G. Y.: Osteopenia in juvenile diabetes—Calcif. Tiss. int.33, 455, 1981.
Spencer E. M., Khalil M., Tobiassen O.: Experimental diabetes in the rat causes an insulin-reversible decrease in renal 25-hydroxyvitamin D3-1α-hydrolase activity—Endocrinology107, 300, 1980.
Ŝtêpán J., Wilczek H., Justová V., Havránek T., Ŝkrha F., Wildtová Z., Formánková J., Pacovský V.: Plasma 25-hydroxycholecalciferol in oral sulfonylurea treated diabetes mellitus—Hormone metabol. Res.14, 98, 1982.
Wientroub S., Eisenberg D., Tardiman R., Weissman S. L., Salama R.: Is diabetic osteoporosis due to microangiopathy?—Lanceti, 983, 1980.
Wiske P. S., Wentworth S. M., Norton J. A. jr.,Epstein S., Johnston C. C. Jr.: Evalaution of bone mass and growth in young diabetics—Metabolism31, 848, 1982.
Witt M. F., White N. H., Santiago J. V., Seino Y., Avioli L. V.: Use of oral calcium loading to characterize the hypercalciuria of young insulin-dependent diabetics—J. clin. Endocrinol.57, 94, 1983.
Wongsurawat N., Armbrecht H. J., Zenser T. V., Davis B. B., Thomas M. L., Forte L. R.: 1,25-Dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 production by isolated renal slices is modulated by diabetes and insulin in the rat—Diabetes32, 302, 1983.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Isaia, G., Bodrato, L., Carlevatto, V. et al. Osteoporosis in type II diabetes. Acta diabet. lat 24, 305–310 (1987). https://doi.org/10.1007/BF02742962
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02742962